{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:22Z","timestamp":1792406482536,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2023M741470"],"award-info":[{"award-number":["No.2023M741470"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82403574"],"award-info":[{"award-number":["No.82403574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["No.SZL202301"],"award-info":[{"award-number":["No.SZL202301"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["No.ZJ202301"],"award-info":[{"award-number":["No.ZJ202301"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017547","name":"Jiangsu Association for Science and Technology","doi-asserted-by":"publisher","award":["No.JSTJ-2024-386"],"award-info":[{"award-number":["No.JSTJ-2024-386"]}],"id":[{"id":"10.13039\/501100017547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103073","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:41:39Z","timestamp":1792132899000},"page":"103073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The CARM1\u2013YIPF2 axis drives breast cancer progression and predicts poor prognosis"],"prefix":"10.1016","volume":"74","author":[{"given":"Xitao","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103073_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251321904","article-title":"Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue","volume":"17","author":"Liang","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103073_bib0002","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103073_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.tranon.2026.103073_bib0004","first-page":"653","article-title":"Tumoral heterogeneity of breast cancer","volume":"74","author":"Roulot","year":"2016","journal-title":"Ann. Biol. Clin. (Paris)"},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-022-01236-0","article-title":"Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41419-025-07416-3","article-title":"PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1","volume":"16","author":"Lu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2026.103073_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151827","article-title":"TRIB3 recruits and stabilizes CARM1 to confer chemoresistance by activating akt signalling in clear cell renal cancer cells","volume":"766","author":"Hu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.tranon.2026.103073_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70386","article-title":"PRMT3 and CARM1: emerging epigenetic targets in cancer","volume":"29","author":"Huang","year":"2025","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.103073_bib0010","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1007\/s11033-023-08645-5","article-title":"Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway","volume":"50","author":"Yang","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.tranon.2026.103073_bib0011","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1021\/acs.jmedchem.4c02106","article-title":"Small-molecule modulators targeting coactivator-associated arginine methyltransferase 1 (CARM1) as therapeutic agents for cancer treatment: current medicinal chemistry insights and emerging opportunities","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0012","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-022-01586-w","article-title":"The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13578-024-01300-x","article-title":"YIPF2 regulates genome integrity","volume":"14","author":"Zhang","year":"2024","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.tranon.2026.103073_bib0014","doi-asserted-by":"crossref","first-page":"p. 242","DOI":"10.1038\/s41419-020-2436-x","article-title":"YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.tranon.2026.103073_bib0015","doi-asserted-by":"crossref","first-page":"p. 462","DOI":"10.1038\/s41419-019-1709-8","article-title":"YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle","volume":"10","author":"Qi","year":"2019","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.tranon.2026.103073_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.tranon.2026.103073_bib0017","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based Survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"Lanczky","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"W1","key":"10.1016\/j.tranon.2026.103073_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0019","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine methylation: the coming of age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.tranon.2026.103073_bib0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","article-title":"PRMTs and arginine methylation: cancer's best-kept secret?","volume":"25","author":"Jarrold","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.103073_bib0021","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.103073_bib0022","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.tranon.2026.103073_bib0023","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/nar\/gkn166","article-title":"The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation","volume":"36","author":"Kleinschmidt","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.tranon.2026.103073_bib0024","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cell.2004.05.009","article-title":"Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53","volume":"117","author":"An","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103073_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116048","article-title":"Protein arginine methyltransferases (PRMTs): orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance","volume":"221","author":"Gao","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0026","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1038\/s41467-024-52507-y","article-title":"PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma","volume":"15","author":"Walton","year":"2024","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.tranon.2026.103073_bib0027","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/cancers15133461","article-title":"PRMT-1 and p120-Catenin as EMT mediators in osimertinib resistance in NSCLC","volume":"15","author":"Racherla","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.tranon.2026.103073_bib0028","article-title":"PRMT1 promotes pancreatic cancer development and resistance to chemotherapy","volume":"5","author":"Ku","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"18","key":"10.1016\/j.tranon.2026.103073_bib0029","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1158\/0008-5472.CAN-23-3829","article-title":"Arginine methylation of DDX3 by PRMT1 mediates mitochondrial homeostasis to promote breast cancer metastasis","volume":"84","author":"Hsu","year":"2024","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.tranon.2026.103073_bib0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41419-021-04381-5","article-title":"PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.tranon.2026.103073_bib0031","article-title":"Arginine methyltransferase PRMT1 regulates p53 activity in breast cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.tranon.2026.103073_bib0032","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/cancers14020306","article-title":"PRMT1 Regulates EGFR and wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer","volume":"14","author":"Suresh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2026.103073_bib0033","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12282-017-0790-z","article-title":"The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells","volume":"25","author":"Nakai","year":"2018","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.103073_bib0034","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2767-9764.CRC-23-0030","article-title":"Targeting fatty acid reprogramming suppresses CARM1-expressing ovarian cancer","volume":"3","author":"Lombardi","year":"2023","journal-title":"Cancer Res. Commun."},{"issue":"36","key":"10.1016\/j.tranon.2026.103073_bib0035","article-title":"Inhibition of CARM1-mediated methylation of ACSL4 promotes ferroptosis in colorectal cancer","volume":"10","author":"Feng","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"10.1016\/j.tranon.2026.103073_bib0036","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00418-016-1527-3","article-title":"Functional characterisation of the YIPF protein family in mammalian cells","volume":"147","author":"Kranjc","year":"2017","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103073_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.708754","article-title":"Characterization of five transmembrane proteins: with focus on the tweety, sideroflexin, and YIP1 domain families","volume":"9","author":"Attwood","year":"2021","journal-title":"Front Cell Dev. Biol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:50:50Z","timestamp":1792403450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S1936523326004092"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103073","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CARM1\u2013YIPF2 axis drives breast cancer progression and predicts poor prognosis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103073"}}